Related Experiment Videos
Catechol-O-methyltransferase: substrate-specificity and stereoselectivity for beta-adrenoceptor agents
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|January 1, 1986
Summary
This study reveals catechol-O-methyltransferase (COMT) enzyme activity with beta-adrenoceptor agents. Rimiterol and dobutamine are better COMT substrates than isoprenaline, with stereoselective O-methylation observed.
Area of Science:
- Biochemistry
- Pharmacology
Background:
- Catechol-O-methyltransferase (COMT) is crucial for metabolizing catecholamines.
- Understanding COMT substrate specificity is vital for drug development and understanding drug metabolism.
Purpose of the Study:
- To investigate the substrate activity of purified pig-liver COMT with several beta-adrenoceptor agents.
- To determine kinetic parameters (Km, Vmax) and apparent first-order rate constants for these substrates.
- To explore the stereoselectivity of COMT-mediated O-methylation.
Main Methods:
- Purified pig-liver catechol-O-methyltransferase was used.
- A sensitive spectrophotometric assay was employed to measure enzyme activity.
- Kinetic parameters (Km, Vmax) and apparent first-order rate constants (Vmax/Km) were determined.
Main Results:
- Rimiterol and dobutamine were identified as significantly better substrates for COMT than isoprenaline.
- Isoetharine showed no improvement over isoprenaline as a COMT substrate.
- Nadolol was not metabolized by COMT.
- O-methylation of isoprenaline and noradrenaline enantiomers was stereoselective, favoring the levo (-) isomer.
Conclusions:
- The study highlights specific steric and stereochemical factors influencing COMT-ligand interactions.
- Rimiterol and dobutamine represent potentially important substrates for COMT.
- Findings provide insights into the metabolism of beta-adrenoceptor agents and COMT enzyme mechanisms.